Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma

Ann Hematol. 2015 Apr;94(4):683-5. doi: 10.1007/s00277-014-2202-1. Epub 2014 Sep 10.

Authors

Takashi Higo¹, Tomomitsu Miyagaki, Fumihiko Nakamura, Akihito Shinohara, Hiroki Asano, Hiroyuki Abe, Naoyuki Senda, Ayumi Yoshizaki, Masashi Fukayama, Mineo Kurokawa

Affiliation

¹ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

PMID: 25199505
DOI: 10.1007/s00277-014-2202-1

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antibodies, Monoclonal, Murine-Derived / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bendamustine Hydrochloride
Drug Eruptions / diagnosis
Female
Humans
Lymphoma, Follicular / drug therapy*
Nitrogen Mustard Compounds / administration & dosage
Nitrogen Mustard Compounds / adverse effects*
Paraneoplastic Syndromes / chemically induced*
Paraneoplastic Syndromes / diagnosis
Pemphigus / chemically induced*
Pemphigus / diagnosis
Recurrence
Rituximab
Salvage Therapy / adverse effects

Substances

Antibodies, Monoclonal, Murine-Derived
Nitrogen Mustard Compounds
Rituximab
Bendamustine Hydrochloride